ID: h-f9e4985929
Hypothesis
Tumor-derived extracellular vesicles as TREM2 ligands
Tumor extracellular vesicles carrying phosphatidylserine activate microglia via TREM2, enhancing neuroprotective functions.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 7 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
Tumor extracellular vesicles carrying phosphatidylserine activate microglia via TREM2, enhancing neuroprotective functions. This is interesting discovery biology but not trial-ready. Requires characterization of PS exposure, EV cargo composition, and demonstration that EVs directly mediate the cystatin-C effect.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Amyloid-beta Plaques<br/>Phospholipid Ligands"]
B["TREM2 Receptor<br/>Ligand Binding"]
C["TYROBP/DAP12<br/>ITAM Phosphorylation"]
D["SYK Kinase<br/>Activation"]
E["PLCG2<br/>IP3 + DAG Generation"]
F["Ca2+ Release<br/>Cytoskeletal Remodeling"]
G["Microglial Phagocytosis<br/>Plaque Compaction"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix7 supports1 contradicts
Supports
TREM2 Alleviates Neuroinflammation and Improves Neurogenesis in ApoE(-/-) Mice by Regulating M1/M2 Microglial Polarization.
Supports
Induced Microglial-like Cells Derived from Familial and Sporadic Alzheimer's Disease Peripheral Blood Monocytes Show Abnormal Phagocytosis and Inflammatory Response to PSEN1 E280A Cholinergic-like Neurons.
Supports
Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Supports
Osteoclast Differentiation is Downregulated by Select Polyphenolic Fractions from Dried Plum via Suppression of MAPKs and Nfatc1 in Mouse C57BL/6 Primary Bone Marrow Cells.
Supports
TGFBI promotes liver fibrosis through remodeling the profibrotic microenvironment by a positive feedback regulatory loop.
Contradicts
Mechanism requires demonstration that EVs are necessary for cystatin-C effect
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — TREM2
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for TREM2 ligands on tumor EVs from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TREM2 ligands on tumor EVs.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0141
Events (7d)
1
Price History
▲3.1%💾 Resource Usage
LLM Tokens
11,154
$0.0335
Total Cost
$0.0335
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF tumor EVs are pre-incubated with phosphatidylserine-blocking agent (Annexin V, 20 μg/mL) before administration to human iPSC-derived microglia, THEN Annexin V-blocked EVs will show ≥60% reduction i | Cystatin-C concentration in culture supernatant: untreated tumor EVs yield ≥150 pg/mL vs Annexin V-blocked EVs yield ≤60 pg/mL (representing ≥60% reduction) | — no observation — | pending | 0.45 |
| IF primary mouse microglia (from TREM2-WT vs TREM2-KO littermates) are treated with tumor-derived EVs isolated from B16-F10 melanoma cells, THEN TREM2-WT microglia will show ≥50% increase in TREM2 dow | TREM2-dependent microglial activation marker upregulation by phospho-flow cytometry: TREM2-WT shows ≥2-fold increase in p-Syk MFI vs vehicle control, while TREM | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 55%
IF primary mouse microglia (from TREM2-WT vs TREM2-KO littermates) are treated with tumor-derived EVs isolated from B16-F10 melanoma cells, THEN TREM2-WT microglia will show ≥50% increase in TREM2 downstream signaling (p-Syk, p-TYROBP by phospho-flow) compared to TREM2-KO microglia within 2 hours of
Predicted outcome: TREM2-dependent microglial activation marker upregulation by phospho-flow cytometry: TREM2-WT shows ≥2-fold increase in p-Syk MFI vs vehicle control,
Falsification: TREM2-KO microglia show equivalent activation (≤20% difference in p-Syk) compared to TREM2-WT microglia, indicating TREM2 is not required for tumor EV-induced activation
pendingconf 45%
IF tumor EVs are pre-incubated with phosphatidylserine-blocking agent (Annexin V, 20 μg/mL) before administration to human iPSC-derived microglia, THEN Annexin V-blocked EVs will show ≥60% reduction in cystatin-C secretion (ELISA) compared to untreated tumor EVs within 24 hours.
Predicted outcome: Cystatin-C concentration in culture supernatant: untreated tumor EVs yield ≥150 pg/mL vs Annexin V-blocked EVs yield ≤60 pg/mL (representing ≥60% redu
Falsification: Annexin V blockade does not significantly reduce cystatin-C secretion (difference <30%), indicating phosphatidylserine on tumor EVs is not the critical TREM2 ligand mediating neuroprotective function
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.